Tennessee · 114

HB 406

Health Care - As introduced, lowers from every three years to every two years, the time within which the advisory committee composed of medical device industry representatives and a representative of the department of economic and community development must review rules regarding the board of pharmacy's oversight of facilities that manufacture, warehouse, and distribute medical devices in order to review the advancements of new medical device technologies. - Amends TCA Title 8; Title 47; Title 56; Title 63 and Title 71.

Bill record: Open States bulk CSV (bills/votes) CC0-1.0

Summary AI-generated

Tennessee HB 406 proposes amending TCA Titles 8, 47, 56, 63, and 71 to reduce the review cycle for specific pharmacy board rules from every three years to every two years. This advisory committee, comprising medical device industry representatives and a department of economic and community development representative, would review advancements in new medical device technologies more frequently under this change.

Software-generated, grounded only in the bill's own fields (it does not invent outcomes, amounts, or dates). Provenance: Open States bulk CSV (bills/votes) CC0-1.0 GovTally LLM enrichment (local oMLX)

Issue tags AI-classified

Classified by a local model from the bill's text; confidence shown. GovTally LLM enrichment (local oMLX)

Sponsors

Roll-call votes on this bill

QuestionChamberResultYeaNayOtherDateSource
HOUSE GOVERNMENT OPERATIONS COMMITTEE: Rec. for pass; ref to Finance, Ways, and… lower pass 0 0 0 Mar 2, 2026 Open States bulk CSV (bills/votes) CC0-1.0
HOUSE INSURANCE COMMITTEE: Rec. for pass. if am., ref. to Government Operations… lower pass 0 0 0 Feb 17, 2026 Open States bulk CSV (bills/votes) CC0-1.0
INSURANCE SUBCOMMITTEE: Rec for pass if am by s/c ref. to Insurance Committee… lower pass 0 0 0 Mar 19, 2025 Open States bulk CSV (bills/votes) CC0-1.0